載入...
T106. KARXT: A M1/M4 PREFERRING MUSCARINIC AGONIST FOR THE TREATMENT OF SCHIZOPHRENIA
BACKGROUND: Xanomeline is a M1 /M4 preferring muscarinic agonist that has demonstrated antipsychotic and pro-cognitive effects in both schizophrenia (Shekar, et al, 2008) and Alzheimer’s disease (Bodick et al, 1997). However, its peripheral cholinergic side effects, including nausea, vomiting and di...
Na minha lista:
| 發表在: | Schizophr Bull |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Oxford University Press
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6455874/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sbz019.386 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|